These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23894620)

  • 21. Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.
    Colbert MD; Flyak AI; Ogega CO; Kinchen VJ; Massaccesi G; Hernandez M; Davidson E; Doranz BJ; Cox AL; Crowe JE; Bailey JR
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities.
    Ratnoglik SL; Jiang DP; Aoki C; Sudarmono P; Shoji I; Deng L; Hotta H
    PLoS One; 2014; 9(6):e98877. PubMed ID: 24901478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase.
    Ingravallo P; Lahser F; Xia E; Sodowich B; Lai VC; Hong Z; Zhong W
    Virus Res; 2001 Jun; 75(2):179-87. PubMed ID: 11325472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
    Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
    J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus.
    Isaguliants MG; Petrakova NV; Mokhonov VV; Pokrovskaya K; Suzdaltzeva YG; Krivonos AV; Zaberezhny AD; Garaev MM; Smirnov VD; Nordenfelt E
    Immunol Lett; 2003 Jul; 88(1):1-13. PubMed ID: 12853154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.
    Kang SM; Choi SH; Park CY; Kim MH; Kim TK; Park JM; Koh MS; Kang HJ; Hwang SB
    J Viral Hepat; 2008 Apr; 15(4):305-13. PubMed ID: 18307593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
    El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
    Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterization of monoclonal antibody specific for NS3 helicase of hepatitis C virus.
    Yang J; Lei YF; Yin W; Wei SH; An QX; Lv X; Hu XB; Xu ZK
    Hybridoma (Larchmt); 2008 Jun; 27(3):181-6. PubMed ID: 18582211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of four novel group-specific bluetongue virus NS3 protein B-cell epitopes.
    Zhang Q; Sun E; Xu Q; Yang T; Wang H; Feng Y; Li J; Lv S; Wu D
    Virol J; 2015 Jun; 12():86. PubMed ID: 26062609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
    Cerino A; Mondelli MU
    J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.
    Gu J; Hardy J; Boo I; Vietheer P; McCaffrey K; Alhammad Y; Chopra A; Gaudieri S; Poumbourios P; Coulibaly F; Drummer HE
    J Virol; 2018 May; 92(9):. PubMed ID: 29467319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step.
    Sabo MC; Luca VC; Prentoe J; Hopcraft SE; Blight KJ; Yi M; Lemon SM; Ball JK; Bukh J; Evans MJ; Fremont DH; Diamond MS
    J Virol; 2011 Jul; 85(14):7005-19. PubMed ID: 21543495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to a novel antigen in acute hepatitis C virus infections.
    Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
    Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.
    Sabo MC; Luca VC; Ray SC; Bukh J; Fremont DH; Diamond MS
    Virology; 2012 Jan; 422(2):174-84. PubMed ID: 22078164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    Das S; Mullick R; Kumar A; Tandon H; Bose M; Gouthamchandra K; Chandra M; Ravishankar B; Khaja MN; Srinivasan N; Das S; Melkote Subbarao S; Karande AA
    J Gen Virol; 2017 May; 98(5):962-976. PubMed ID: 28221101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and application of monoclonal antibody against hepatitis C virus nonstructual protein three.
    Shi H; Xie L; Shi H; Yan L; Duan Z
    Hybridoma (Larchmt); 2012 Feb; 31(1):54-9. PubMed ID: 22316486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.
    Li C; Candotti D; Allain JP
    J Virol; 2001 Dec; 75(24):12412-20. PubMed ID: 11711631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.